Patients with cancer and preexisting depression experience a significantly higher risk for cancer-specific mortality.

Topline phase 3 ARISE trial results show oral solengepras 150mg significantly reduces OFF time and improves motor/non-motor function in Parkinson disease.

Around 1 in 9 older adults in the US have used cannabis in the past 12 months meet the criteria for cannabis use disorder.

Worse parent-reported asthma control among children with asthma is associated with household e-cigarette and household tobacco use.

An upward trend in medical cannabis use between 2016 and 2024 underscores expanded licensure and therapeutic applications for cannabis.

Lower cognitive function in global cognition, episodic memory, and perceptual speed is associated with increased stroke risk among older adults.

General adult psychiatrist Tracey Marks outlines her journey into content creation and her objectives for providing mental health education.

Utilizing machine learning to assess distinct depressive symptoms improves the identification of adults with suicidal ideation.

Among individuals living with HIV, the inability to afford veterinary care for pets is linked to increased depression and anxiety symptoms.

Benzodiazepine prescription rates declined from 2013 to 2024, including net decreases in prevalence across certain age groups.

Topline phase 3 results show tasimelteon significantly advances sleep onset in adults with delayed sleep-wake phase disorder.

Dementia among older adults in China correlates with a substantial increase in the need for functional support and routine safety monitoring.